Topics

Glioblastoma | Treatment | Targeted therapy | Vebreltinib

Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy > Vebreltinib

Liu X, Wang X, Yan P, Zong D, Guo W, He X.
Treatment of a newly diagnosed glioblastoma harboring MET amplification with vebreltinib in combination with radiotherapy: a case report.
Discov Oncol. 2025 Jun 17;16(1):1133. doi: 10.1007/s12672-025-02979-1. PMID: 40526245. Case report. ˍ

Bao Z, Xue Y, Liu Y, Li S, Wang L, Qu Y, Mou Y, Yu R, Wu J, Yao Y, Shu K, Hu G, Cai L, Li W, Qiu X, Li Y, Zhang L, Qi S, Ji Y, Ma C, Ma W, Li G, Tao R, Sun C, Chen L, Lv SQ, Liang P, Pan H, Peter WYM, Danny CTM, Mao Q, Wei X, Jiang T.
Vebreltinib for Previously Treated Astrocytoma, IDH-Mutant, Grade 4, and Glioblastoma, IDH Wild-Type with PTPRZ1-MET Fusion Gene: A Multicenter, Phase III Randomized, Open-Label Trial.
Cancer Commun (Lond). 2026 Mar 11;46:0019. doi: 10.34133/cancomm.0019. PMID: 41821581. Trial registration ID: CTR20181664. ˍ